Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
Abstract Cell-based immunotherapies (CBIs), notably exemplified by chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy, have emerged as groundbreaking approaches for cancer therapy. Nevertheless, akin to various other therapeutic modalities, tumor cells employ counterstrategies to mani...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Jezik: | English |
| Izdano: |
BMC
2024-01-01
|
| Serija: | Journal of Biomedical Science |
| Teme: | |
| Online dostop: | https://doi.org/10.1186/s12929-024-00998-8 |